Beijing Foyou Pharma CO.,LTD (SHA:601089)
23.59
-0.26 (-1.09%)
At close: Mar 9, 2026
SHA:601089 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Market Capitalization | 11,040 | 7,488 | 8,275 | 7,358 | - | - | Upgrade
|
| Market Cap Growth | 51.51% | -9.51% | 12.46% | - | - | - | Upgrade
|
| Enterprise Value | 9,015 | 5,284 | 5,917 | 5,133 | - | - | Upgrade
|
| Last Close Price | 23.59 | 15.52 | 16.15 | 14.05 | - | - | Upgrade
|
| PE Ratio | 24.30 | 15.32 | 16.93 | 16.77 | - | - | Upgrade
|
| PS Ratio | 3.23 | 2.17 | 2.48 | 2.27 | - | - | Upgrade
|
| PB Ratio | 2.98 | 2.11 | 2.38 | 2.32 | - | - | Upgrade
|
| P/TBV Ratio | 3.11 | 2.20 | 2.49 | 2.43 | - | - | Upgrade
|
| P/FCF Ratio | 187.59 | 25.02 | 43.59 | 14.03 | - | - | Upgrade
|
| P/OCF Ratio | 21.44 | 10.84 | 14.89 | 11.15 | - | - | Upgrade
|
| EV/Sales Ratio | 2.64 | 1.53 | 1.77 | 1.58 | - | - | Upgrade
|
| EV/EBITDA Ratio | 15.45 | 9.57 | 10.54 | 10.27 | - | - | Upgrade
|
| EV/EBIT Ratio | 18.82 | 11.28 | 12.29 | 11.86 | - | - | Upgrade
|
| EV/FCF Ratio | 153.17 | 17.66 | 31.17 | 9.79 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.04 | 0.04 | 0.11 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.13 | 0.21 | 0.24 | 0.33 | 0.25 | Upgrade
|
| Debt / FCF Ratio | 0.49 | 0.25 | 0.66 | 0.23 | 0.41 | 0.39 | Upgrade
|
| Net Debt / Equity Ratio | -0.55 | -0.65 | -0.69 | -0.76 | -0.33 | -0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.61 | -4.16 | -4.29 | -4.84 | -0.96 | -0.69 | Upgrade
|
| Net Debt / FCF Ratio | -34.65 | -7.68 | -12.68 | -4.61 | -1.18 | -1.09 | Upgrade
|
| Asset Turnover | 0.73 | 0.74 | 0.75 | 1.00 | 1.47 | 1.48 | Upgrade
|
| Inventory Turnover | 3.20 | 3.50 | 3.49 | 3.14 | 2.91 | 2.70 | Upgrade
|
| Quick Ratio | 2.46 | 2.38 | 2.98 | 2.86 | 1.07 | 1.08 | Upgrade
|
| Current Ratio | 2.90 | 2.69 | 3.33 | 3.20 | 1.48 | 1.57 | Upgrade
|
| Return on Equity (ROE) | 13.00% | 13.99% | 14.79% | 20.01% | 28.42% | 28.50% | Upgrade
|
| Return on Assets (ROA) | 6.42% | 6.25% | 6.79% | 8.36% | 11.50% | 10.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 26.09% | 36.66% | 47.17% | 49.60% | 38.55% | 35.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.70% | 12.90% | 13.60% | 13.20% | 27.60% | 29.20% | Upgrade
|
| Earnings Yield | 4.19% | 6.53% | 5.91% | 5.96% | - | - | Upgrade
|
| FCF Yield | 0.53% | 4.00% | 2.29% | 7.13% | - | - | Upgrade
|
| Dividend Yield | 2.10% | 3.22% | 3.10% | 2.85% | - | - | Upgrade
|
| Payout Ratio | 50.65% | 48.41% | 39.81% | 25.34% | 36.32% | 45.40% | Upgrade
|
| Buyback Yield / Dilution | -0.96% | 1.94% | -13.55% | -16.75% | -0.44% | -0.35% | Upgrade
|
| Total Shareholder Return | 1.14% | 5.16% | -10.45% | -13.91% | -0.44% | -0.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.